Lung Health

  • A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, Stanford Medicine scientists have found. The discovery has important implications for preventing severe COVID-19.

  • Osteoarthritis linked to allergic inflammation

    A connection found between asthma, eczema and osteoarthritis indicates that drugs to treat allergic conditions could be used in future studies aimed at slowing the progression of osteoarthritis.

  • Hints into long COVID

    People with lower levels of an antiviral antibody as well as those with lung disease take longer to clear COVID-19 symptoms, say Stanford Medicine researchers.

  • Gummy phlegm and COVID-19

    Levels of a stringy, spongy substance soar in the sputum of COVID-19 patients requiring intubation, accounting for at least some of their breathing trouble. Development of an off-patent drug may prevent it.

  • Possible treatment for mucus-induced lung diseases

    Stanford Medicine investigators and their collaborators have designed a compound that’s uniquely capable of blocking excessive mucus secretion — a hallmark of several serious respiratory disorders.

  • Deadly disease races among crowded inmates

    Stanford infectious disease expert Jason Andrews has spent years studying the spread of tuberculosis in crowded Brazilian prisons and surrounding communities — an overlooked global health crisis.

  • Stanford opens long COVID clinic

    With research showing up to 30% of COVID-19 patients experiencing lingering symptoms, Stanford Health Care treats such “long haulers” with multidisciplinary teams.

  • Wildfires and school ventilation

    With the COVID-19 pandemic and the growth of wildfires, California schools need to improve their air quality, according to Stanford pediatrician Lisa Patel. Fortunately, the funds are available.

  • Coronavirus likely first infects upper airway cells

    A Stanford Medicine study reports that the coronavirus likely first infects upper airway cells and that hypertension drugs probably don't increase the risk of infection.

  • Researchers on wildfires’ health impacts

    California’s massive wildfires bring a host of health concerns. In a Q&A, Kari Nadeau and Mary Prunicki of the Sean N. Parker Center for Allergy and Asthma Research at Stanford discuss the threats posed by air pollution from the fires.

  • Vaping linked to higher COVID-19 risk

    Data collected in May shows that teenagers and young adults who vape face a much higher risk of COVID-19 than their peers who do not vape, Stanford researchers found.

  • Immunologist Chitra Dinakar dies at 54

    Dinakar founded Stanford Health Care’s first allergy, asthma and immunodeficiency clinic for adult patients, which opened its doors last year.


Related Websites

Lung Health Topics